Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
povidone-iodine + bupivacaine hydrochloride + triamcinolone
- Development stage
- Unknown
- Lead developer
- Rx Pharma-pack
- Modality
- Small Molecules
- Administration
- Topical, Parenteral
01
Overview
A small-molecule combination kit comprising **povidone-iodine**, **bupivacaine hydrochloride**, and **triamcinolone**. The product is used in procedural analgesia and anesthesia settings, where povidone-iodine serves as a topical antiseptic skin-preparation component, bupivacaine hydrochloride provides local anesthetic blockade of voltage-gated sodium channels, and triamcinolone supplies corticosteroid anti-inflammatory activity through glucocorticoid receptor agonism. Publicly described examples include packaged kits such as P-CARE K40MX and P-CARE K80MX distributed by RX Pharma-Pack. Based on the provided context, this is a combination convenience kit rather than a novel molecular entity, and the combined kit labeling has not been found by FDA to be approved as safe and effective.
- Other names
- Marcaine + Kenalog + povidone-iodinepovidone-iodine + bupivacaine hydrochloride + triamcinolone acetonide
02
Targets
NaV (Voltage-gated sodium channels)GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on povidone-iodine + bupivacaine hydrochloride + triamcinolone.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on povidone-iodine + bupivacaine hydrochloride + triamcinolone.